FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer

Autor: Janice W. H. Tsang, Aleksandra K. Zwolinska, Anne Feltes, San Yu Wong, Ui-Soon Khoo, Maja Petkovic, Ana R. Gomes, Yuen-Nei Cheung, Christina T. Karadedou, Jie Chen, Eric Lam, Ka-Kei Ho, Jan J. Brosens, Kelvin Y.K. Chan
Rok vydání: 2011
Předmět:
Vascular Endothelial Growth Factor A
Cancer Research
Response element
TRANSCRIPTION FACTOR FOXO3A
Histone Deacetylase 2
GROWTH-INHIBITION
CELL BIOLOGY
chemistry.chemical_compound
LEUKEMIC-CELLS
GENETICS & HEREDITY
skin and connective tissue diseases
GENE-EXPRESSION
Histone deacetylase 2
Forkhead Box Protein O3
Forkhead Transcription Factors
VEGF
SOLID TUMORS
DUAL INHIBITOR
Gene Expression Regulation
Neoplastic

Vascular endothelial growth factor
Female
transcription
TYROSINE KINASE INHIBITOR
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Breast Neoplasms
Biology
Article
breast cancer
LUNG-CANCER
Cell Line
Tumor

Genetics
Humans
Oncology & Carcinogenesis
FOXO3a
Molecular Biology
Transcription factor
Science & Technology
Forkhead Box Protein M1
Vascular Endothelial Growth Factor A - metabolism
FOXM1
1103 Clinical Sciences
Lapatinib
Breast Neoplasms - metabolism
Forkhead Transcription Factors - metabolism
ONCOLOGY
chemistry
Quinazolines
Cancer research
GEFITINIB IRESSA
1112 Oncology And Carcinogenesis
Chromatin immunoprecipitation
Zdroj: Oncogene
ISSN: 1476-5594
0950-9232
DOI: 10.1038/onc.2011.368
Popis: Vascular endothelial growth factor (VEGF) has a central role in breast cancer development and progression, but the mechanisms that control its expression are poorly understood. Breast cancer tissue microarrays revealed an inverse correlation between the Forkhead transcription factor Forkhead box class O (FOXO)3a and VEGF expression. Using the lapatinib-sensitive breast cancer cell lines BT474 and SKBR3 as model systems, we tested the possibility that VEGF expression is negatively regulated by FOXO3a. Lapatinib treatment of BT474 or SKBR3 cells resulted in nuclear translocation and activation of FOXO3a, followed by a reduction in VEGF expression. Transient transfection and inducible expression experiments showed that FOXO3a represses the proximal VEGF promoter, whereas another Forkhead member, FOXM1, induces VEGF expression. Chromatin immunoprecipitation and oligonucleotide pull-down assays showed that both FOXO3a and FOXM1 bind a consensus Forkhead response element (FHRE) in the VEGF promoter. Upon lapatinib stimulation, activated FOXO3a displaces FOXM1 bound to the FHRE before recruiting histone deacetylase 2 (HDAC2) to the promoter, leading to decreased histones H3 and H4 acetylation, and concomitant transcriptional inhibition of VEGF. These results show that FOXO3a-dependent repression of target genes in breast cancer cells, such as VEGF, involves competitive displacement of DNA-bound FOXM1 and active recruitment of transcriptional repressor complexes.
link_to_OA_fulltext
Databáze: OpenAIRE